Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2013; 19(20): 3062-3068
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3062
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3062
Table 1 Study population baseline characteristics n (%)
| Placebo | Glucomannan | |
| Patients recruited | 45 | 44 |
| Male/female | 21/22 | 21/20 |
| Age mean, yr | 11.3 ± 2.5 | 11.6 ± 3.0 |
| Self-reported frequency of pain1 | ||
| Pain 1-3 times per month | ||
| Pain 1-2 times per week | 12 (27.9) | 9 (21.9) |
| Pain > 2 times per week | 13 (30.2) | 9 (21.9) |
| Pain every day | 14 (32.6) | 14 (34.1) |
| 4 (9.3) | 9 (21.9) | |
| Severity of pain1 | ||
| “face 0” | 0 (0) | 0 (0) |
| “face 1” | 5 (11.6) | 2 (4.8) |
| “face 2” | 18 (40.8) | 13 (31.7) |
| “face 3” | 15 (34.8) | 16 (39.0) |
| “face 4” | 5 (11.6) | 8 (19.5) |
| “face 5” | 0 (0) | 2 (4.8) |
| Self-reported absenteeism from school | 21 | 21 |
| Self-reported alterations in daily activities | 29 | 27 |
| Number of subjects who required rescue therapy | 20 | 25 |
- Citation: Horvath A, Dziechciarz P, Szajewska H. Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: A randomized trial. World J Gastroenterol 2013; 19(20): 3062-3068
- URL: https://www.wjgnet.com/1007-9327/full/v19/i20/3062.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i20.3062